PICI Network Researchers Featured at Spotlight on Immuno-Oncology Conference

Six members of the Parker Institute for Cancer Immunotherapy (PICI) Network will present at the 2023 Spotlight on Immuno-Oncology conference, Aug. 1 and 2 in Seattle and online.

Hosted by the American Society of Gene & Cell Therapy (ASGCT), the event will focus on novel CAR designs and approaches beyond B-cell malignancies, genome and epigenome editing, direct in vivo delivery for cancer immunotherapy, and other topics.

The six PICI Network presenters, in order of their presentations, are:

• Carl H. June, MD, Center Director of PICI at the University of Pennsylvania
• Robbie Majzner, MD, of Stanford Medicine
• Yvonne Y. Chen, PhD, of the University of California, Los Angeles
• Christopher A. Klebanoff, MD, of Memorial Sloan Kettering Cancer Center
• Justin Eyquem, PhD, of the University of California, San Francisco (UCSF)
• Kole Roybal, PhD, also of UCSF

Below are details about their presentations. All times are Pacific Daylight Time. Livestream and on-demand video options also are available.

Programming is subject to change. For the most current information, visit the conference agenda. Follow the meeting live on Twitter using the hashtag #IO23ASGCT.

Tuesday, Aug. 1

Session: B-Cell Malignancies and Beyond

Presenter: Carl H. June, MD (Twitter: @CarlHJune)
Topic: CAR T Cell Clinical Trials
Time: 9-9:25 a.m.

Session: Novel CAR Designs and Approaches

Presenter: Robbie Majzner, MD (Twitter: @Majzner_Lab)
Topic: Novel CAR Designs
Time: 10:15-10:40 a.m.

Presenter: Yvonne Y. Chen, PhD
Topic: Engineering Next-Generation CAR-T Cells for Cancer Immunotherapy
Time: 11:05-11:30 a.m.

Session: TCRs

Presenter: Christopher A. Klebanoff, MD
Topic: Immunogenicity and Therapeutic Targeting of Recurrently Mutated “Public” Neoantigens Using TCR Gene Therapy
Time: 1:50-2:15 p.m.

Wednesday, Aug. 2

Session: Genome and Epigenome Editing for Cancer Immunotherapy

Presenter: Justin Eyquem, PhD (Twitter: @J_Eyquem)
Topic: Bridging Synthetic Immunology and Genome Editing to advance T Cell Therapies
Time: 8:25-8:50 a.m.

Presenter: Kole Roybal, PhD (Twitter: @KoleRoybal)
Topic: To be publicized
Time: 9:15-9:40 a.m.